Police have arrested a Toronto woman in connection with three recent homicides and investigators say that they believe two of the victims may have been 'randomly targeted.'
Ozempic ads seem to be everywhere. Doctors and ethics experts are worried about that
With ads popping up on TV, social media, giant billboards and at professional sports games, Canadians may be feeling bombarded by marketing for Ozempic and sister drug Rybelsus.
Some have taken to social media to document their most remarkable sightings, including Ozempic and Rybelsus ads wrapping entire streetcars and encircling the field at Toronto Blue Jays baseball games.
Both medications are semaglutide drugs manufactured by Novo Nordisk -- Ozempic is the injectable form and Rybelsus is the pill form. They're approved in Canada for treating Type 2 diabetes and often prescribed off-label to treat obesity.
But some doctors and medical ethics experts say the marketing campaign is too aggressive. They worry that such intense saturation of advertising could lead to pressure on doctors to prescribe Ozempic to patients who don't actually need it, leading to shortages for those who do.
- 5 Things to Know newsletter: Sign up to start your day with the biggest stories
- Nightly Briefing newsletter: Sign up for coverage of the day’s most compelling news
- Get the Â鶹ӰÊÓ App now for breaking news alerts and all the top stories
They also worry that serious potential side-effects such as pancreatitis and gallbladder inflammation, although rare, could start to appear due to the sheer volume of people taking the drug.
"What the (company is) trying to do is to put the ads in so many places that it's very difficult to avoid seeing them," said Dr. Joel Lexchin, a professor emeritus at York University who studies pharmaceutical policy.
Health Canada allows pharmaceutical companies to run "reminder ads," Lexchin said. Advertisements can say the name of the drug but they can't say what conditions it treats. Instead, they urge people to ask their doctors about the drug.
Kate Hanna, a spokeswoman for Novo Nordisk's Canadian arm, told The Canadian Press on Monday that the national marketing campaign is aimed at people with Type 2 diabetes.
"Diabetes is not being effectively managed and this is not a niche market. Diabetes is a public health crisis," Hanna said.
"There really is a need to educate Canadians on Type 2 diabetes risk and support those living with the condition to engage their health-care professional for optimal disease care."
But the marketing influx comes on the heels of an explosion of unofficial Ozempic promotion for weight loss from social media influencers and celebrities. Canadian doctors and pharmacists have already confirmed an enormous increase in patients asking for the drug for that purpose.
The ever-present reminder ads are likely to prompt more people wanting to lose weight to put pressure on their doctors to prescribe Ozempic, even though they don't have diabetes or meet the clinical criteria for obesity, Lexchin said.
"It's not approved for treating somebody who wants to lose 10 or 15 pounds so that they can fit into a bathing suit or a tuxedo or what have you. But the ads that you're seeing don't tell you that," he said.
"You've tried to lose weight, you figure if you can get from 180 to 160 (pounds) you'll be in much better shape," Lexchin said. "You see one of these ads and you go see your doctor. And that's what this kind of advertising is designed to do."
Even diabetes and obesity specialists who praise Ozempic for its effectiveness in treating those conditions are worried about Novo Nordisk's marketing strategy.
"I'm not impressed," said Dr. Ehud Ur, an endocrinologist at St. Paul's Hospital and Vancouver General Hospital.
Ur noted that he has been involved with Novo Nordisk for "many different drugs" and that he's personally found the company's practices to be ethical.
But "the push to get everybody and their dog on Ozempic" is problematic, he said.
"We've never had a drug as good as Ozempic. But on the other hand we've never had so much interest and so much pressure on people to prescribe it," Ur said.
Like with all prescribed medications, doctors need to do a risk versus benefit assessment, he said.
According to the manufacturer's website, minor side-effects include nausea, vomiting, diarrhea, constipation and abdominal pain.
More serious but rare risks include inflammation of the pancreas, gallbladder problems, kidney issues and low blood sugar. Animal studies found an association between Ozempic and thyroid tumours in rats, but it's not clear whether that's a real risk in humans.
For someone with diabetes or obesity, the risks of not getting effective treatment often outweigh the rare potential risks associated with Ozempic, Ur said.
But for someone who wants to lose 10 to 20 pounds for "cosmetic" reasons, the medical benefit may not be worth the risk.
"Where you are placed in that continuum of risk is really an important calculation for a physician," Ur said.
The problem with the mass Ozempic advertising campaign is that it cultivates an impression among people that it's a "wonder drug that's going to help them lose weight," he said.
If they convince their doctor to prescribe it, those patients "are now going to expose themselves to the risk of a medical intervention without a huge amount of medical benefit."
Huge demand for Ozempic could also create shortages for patients who rely on it for diabetes control, Ur said, noting he has patients who have already had trouble with the drug being on back order.
When asked to respond to that concern, Hanna of Novo Nordisk said the company is "ramping up our production to meet the demands."
She also said there are no current shortages in Canada.
Another issue, Ur said, is that mathematically, the more people who take the drug, the more likely it is that someone will suffer one of the rare side-effects.
"I think ultimately (Novo Nordisk) may be shooting themselves in the foot by this strategy," Ur said.
Despite the criticisms, the company's Ozempic marketing campaign complies with Canadian law, Health Canada said in an email on Monday.
"To date, (Health Canada) has assessed 30 complaints. The current advertisements of Ozempic that have been reviewed are deemed compliant with the current advertising provisions in Canada," the email said.
Both Lexchin and Ur said Canada should not allow any direct-to-consumer advertising for prescription drugs, similar to regulations in the U.K. and Europe.
Kerry Bowman, a bioethicist at the University of Toronto, said he finds the company's advertising blitz "disturbing."
"They're taking advantage of Canadian law because they're staying within the parameters of it, but not the spirit of it because, you know, the saturation of these ads is incredible," Bowman said.
"This is not about public health, this is not about well-being. This is about marketing and it is very, very much for profit. And so there's no question about that."
This report by The Canadian Press was first published June 20, 2023.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
CTVNews.ca Top Stories
NDP house leader says House dysfunction will be a factor in future confidence votes
NDP House leader Peter Julian says there's more his party wants to do in Parliament before the next election, but if the current dysfunction continues it will become a factor in how they vote on a confidence measure.
Canadian family stuck in Lebanon anxiously awaits flight options amid Israeli strikes
A Canadian man who is trapped in Lebanon with his family says they are anxiously waiting for seats on a flight out of the country, as a barrage of Israeli airstrikes continues.
A teen charged with the murder of another teen on Prince Edward Island last year has pleaded guilty to a lesser charge of manslaughter.
BREAKING
The jury tasked with determining if Canadian musician Jacob Hoggard sexually assaulted a young woman in northeastern Ontario eight years ago began deliberating Friday after nearly two weeks of testimony that saw the singer and his accuser give starkly different accounts of what happened.
BREAKING
A northeastern Ontario jury has started deliberating in Canadian musician Jacob Hoggard's sexual assault trial, we can now tell you what they weren't allowed to hear.
Former Colorado county clerk Tina Peters sentenced to 9 years for voting data scheme
A judge ripped into a Colorado county clerk for her crimes and lies before sentencing her Thursday to nine years behind bars for a data-breach scheme spawned from the rampant false claims about voting machine fraud in the 2020 presidential race.
Yazidi woman captured by ISIS rescued in Gaza after more than a decade in captivity
A 21-year-old Yazidi woman has been rescued from Gaza where she had been held captive by Hamas for years after being trafficked by ISIS.
Airlines' challenge of Canada's passenger protection rules rejected by Supreme Court
Canada's airlines have failed in their challenge of air passenger protection rules that the federal government implemented in 2019.
Local Spotlight
Chantal Kreviazuk is set to return to Winnipeg to mark a major milestone in her illustrious musical career.
From the beaches of Cannes to the bustling streets of New York City, a new film by a trio of Manitoba directors has toured the international film festival circuit to much pomp and circumstance.
A husband and wife have been on the road trip of a lifetime and have decided to stop in Saskatchewan for the winter.
The grave of a previously unknown Canadian soldier has been identified as a man from Hayfield, Man. who fought in the First World War.
A group of classic car enthusiasts donated hundreds of blankets to nursing homes in Nova Scotia.
Moving into the second week of October, the eastern half of Canada can expect some brisker fall air to break down from the north
What does New Westminster's təməsew̓txʷ Aquatic and Community Centre have in common with a historic 68,000-seat stadium in Beijing, an NFL stadium and the aquatics venue for the Paris Olympics? They've all been named among the world's most beautiful sports venues for 2024.
The last living member of the legendary Vancouver Asahi baseball team, Kaye Kaminishi, died on Saturday, Sept. 28, surrounded by family. He was 102 years old.
New data from Greater Vancouver and the Fraser Valley shows a surge in supply and drop in demand in the region's historically hot real estate market.